Clover Biopharmaceuticals, Ltd. 2197.HK Stock
Clover Biopharmaceuticals, Ltd. Price Chart
Clover Biopharmaceuticals, Ltd. 2197.HK Financial and Trading Overview
| Clover Biopharmaceuticals, Ltd. stock price | 0.35 HKD |
| Previous Close | 0.65 HKD |
| Open | 0.65 HKD |
| Bid | 0.61 HKD x N/A |
| Ask | 0.63 HKD x N/A |
| Day's Range | 0.61 - 0.66 HKD |
| 52 Week Range | 0.53 - 3.66 HKD |
| Volume | 4.26M HKD |
| Avg. Volume | 4.99M HKD |
| Market Cap | 789.38M HKD |
| Beta (5Y Monthly) | 4.119 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.12 HKD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.97 HKD |
2197.HK Valuation Measures
| Enterprise Value | 15.19M HKD |
| Trailing P/E | N/A |
| Forward P/E | 0.539823 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3071.528 |
| Price/Book (mrq) | 27.727274 |
| Enterprise Value/Revenue | 59.124 |
| Enterprise Value/EBITDA | -0.005 |
Trading Information
Clover Biopharmaceuticals, Ltd. Stock Price History
| Beta (5Y Monthly) | 4.119 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 3.66 HKD |
| 52 Week Low | 0.53 HKD |
| 50-Day Moving Average | 0.69 HKD |
| 200-Day Moving Average | 1.23 HKD |
2197.HK Share Statistics
| Avg. Volume (3 month) | 4.99M HKD |
| Avg. Daily Volume (10-Days) | 3.72M HKD |
| Shares Outstanding | 1.29B |
| Float | 736.2M |
| Short Ratio | N/A |
| % Held by Insiders | 38.38% |
| % Held by Institutions | 13.86% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | June 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -685014.00000000000000000000000000000000% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -45.49% |
| Return on Equity (ttm) | -648.52% |
Income Statement
| Revenue (ttm) | 257K HKD |
| Revenue Per Share (ttm) | 0 HKD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -475643000 HKD |
| EBITDA | -2985733888 HKD |
| Net Income Avi to Common (ttm) | -665193984 HKD |
| Diluted EPS (ttm) | -0.71 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.28B HKD |
| Total Cash Per Share (mrq) | 0.99 HKD |
| Total Debt (mrq) | 455.94M HKD |
| Total Debt/Equity (mrq) | 1596.83 HKD |
| Current Ratio (mrq) | 1.185 |
| Book Value Per Share (mrq) | 0.022 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1562470016 HKD |
| Levered Free Cash Flow (ttm) | -1376232192 HKD |
Profile of Clover Biopharmaceuticals, Ltd.
| Country | Hong Kong |
| State | N/A |
| City | Shanghai |
| Address | Park Place |
| ZIP | N/A |
| Phone | 86 40 0883 3405 |
| Website | https://www.cloverbiopharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 681 |
Clover Biopharmaceuticals, Ltd., a biotechnology company, engages in the research, development, and commercialization of vaccines and biologic therapeutic candidates. The company develops SCB-2019 (CpG 1018/Alum), an adjuvanted protein-based COVID-19 vaccine candidate; AdimFlu-S (QIS), a quadrivalent vaccine for the treatment of influenza; SCB-2020S (CAS-1) and Multivalent SARS-CoV-2, a COVID-19 vaccine candidate; SCB-313, a trimeric fusion protein for the treatment of malignant ascites, malignant pleural effusions, and peritoneal carcinomatosis to address the global unmet medical need of intracavitary malignancies; SCB-219M, a human thrombopoietin receptor agonist (TPO-RA), which is in Phase 1 trial for the treatment of chemotherapy-induced thrombocytopenia; and SCB-1001, a rabies vaccine candidate. It develops its vaccines through Trimer-Tag technology platform. Clover Biopharmaceuticals, Ltd. was founded in 2007 and is headquartered in Shanghai, China.
Q&A For Clover Biopharmaceuticals, Ltd. Stock
What is a current 2197.HK stock price?
Clover Biopharmaceuticals, Ltd. 2197.HK stock price today per share is 0.35 HKD.
How to purchase Clover Biopharmaceuticals, Ltd. stock?
You can buy 2197.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Clover Biopharmaceuticals, Ltd.?
The stock symbol or ticker of Clover Biopharmaceuticals, Ltd. is 2197.HK.
Which industry does the Clover Biopharmaceuticals, Ltd. company belong to?
The Clover Biopharmaceuticals, Ltd. industry is Biotechnology.
How many shares does Clover Biopharmaceuticals, Ltd. have in circulation?
The max supply of Clover Biopharmaceuticals, Ltd. shares is 1.29B.
What is Clover Biopharmaceuticals, Ltd. Price to Earnings Ratio (PE Ratio)?
Clover Biopharmaceuticals, Ltd. PE Ratio is now.
What was Clover Biopharmaceuticals, Ltd. earnings per share over the trailing 12 months (TTM)?
Clover Biopharmaceuticals, Ltd. EPS is -0.12 HKD over the trailing 12 months.
Which sector does the Clover Biopharmaceuticals, Ltd. company belong to?
The Clover Biopharmaceuticals, Ltd. sector is Healthcare.